Ellen Snow

Chief Accounting Officer, AlerisLife Inc.

Companies

Akebia Therapeutics, Inc.Chief financial officer Jul 18, 2023 to Feb 2, 2024¹
Pear Therapeutics (United States)Chief Accounting Officer Dec 7, 2021 to Feb 17, 2023²
AlerisLife Inc.Chief Accounting Officer Sep 3, 2019 to Dec 16, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Akebia Therapeutics, Inc. AKBA519,300 shares⁴$366.6K at $0.71Jan 31, 2024
Pear Therapeutics (United States)23,318 shares⁵Jan 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 31, 2024Granted 149,300 shares of Akebia Therapeutics, Inc.⁴
Jul 31, 2023Granted 370,000 shares of Akebia Therapeutics, Inc.⁶
Jan 20, 2023Sold 8,027 shares at $1.13 of Pear Therapeutics (United States)⁵
Jan 14, 2023Exercised options 20,320 shares of Pear Therapeutics (United States)⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAkebia Therapeutics, Inc., Chief financial officer
2
SEC EDGARPear Therapeutics (United States), Chief Accounting Officer
3
SEC EDGARAlerisLife Inc., Chief Accounting Officer
4
SEC EDGARAkebia Therapeutics, Inc. shares after the filing of Jan 31, 2024
5
SEC EDGARPear Therapeutics (United States) shares after the filing of Jan 20, 2023
6
SEC EDGARForm 4 filed Aug 1, 2023
7
SEC EDGARForm 4 filed Jan 18, 2023